EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in theranostics and oncology PET: emerging radionuclides and targets

Tadashi Watabe, Kenji Hirata, Mami Iima, Masahiro Yanagawa, Tsukasa Saida, Akihiko Sakata, Satoru Ide, Maya Honda, Ryo Kurokawa, Kentaro Nishioka, Mariko Kawamura, Rintaro Ito und 6 weitere

Annals of Nuclear Medicine · 2025-09 · 39 (9) · 909-921

DOI: 10.1007/s12149-025-02090-z ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Nuclear Medicine, online erschienen am 27.07.2025. Verfasst von Tadashi Watabe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. watabe.tadashi.med@osaka…. Hauptthemen laut MEDLINE: Neoplasms, Radioisotopes, Positron-Emission Tomography, Theranostic Nanomedicine. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Osaka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Theranostics, a novel integrated approach that combines cancer diagnosis and therapy by switching the radionuclide, has attracted growing attention. Various oncology PET probes other than FDG have been developed for the highly sensitive and precise detection of many types of cancer with the advancements in PET scanners, supporting the innovative development in theranostics. In therapeutic applications, radioligand therapy targeting somatostatin receptors (SSTR) and prostate-specific membrane antigen (PSMA) has already demonstrated significant clinical benefits. Terbium-161 ( 161 Tb) has emerged as a new beta and Auger electron emitter, showing greater therapeutic efficacy compared to 177 Lu. Alpha emitters, such as astatine ( 211 At), are currently being evaluated in investigator-initiated clinical trials, with preliminary efficacy data reported for [ 211 At]NaAt in patients with radioiodine-refractory thyroid cancer. Novel pan-tumor targeting agents, such as TROP-2, Nectin-4, LAT1, GPC-1, and EphA2, are also under development, and clinical translation of radioligand therapy is anticipated. These innovations in theranostics are expected to further broaden the scope of precision medicine in oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRadioisotopesPositron-Emission TomographyTheranostic NanomedicineMedical OncologyHumansPrecision MedicineMolecular Targeted TherapyAnimalsRadiopharmaceuticals

Stichwörter der Autor:innen

AstatinePSMAPositron emission tomographyRadioligand therapySSTRTerbiumTheranostics

Substanzen

RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. watabe.tadashi.med@osaka-u.ac.jp.
  • Institute for Radiation Sciences, The University of Osaka, Suita, Japan. watabe.tadashi.med@osaka-u.ac.jp.
  • Department of Diagnostic Imaging, Faculty of Medicine, Hokkaido University, Nishi 7, Kita 15, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
  • Department of Fundamental Development for Advanced Low Invasive Diagnostic Imaging, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-ku, Nagoya, Aichi, 466-8550, Japan.
  • Department of Radiology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Department of Radiology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Förderung

  • The University of Osaka

Zitieren

APA

Watabe, T., Hirata, K., Iima, M., Yanagawa, M., Saida, T., Sakata, A., Ide, S., Honda, M., Kurokawa, R., Nishioka, K., Kawamura, M., Ito, R., Takumi, K., Oda, S., Sugawara, S., Sofue, K., Ueda, D., & Naganawa, S. (2025). Recent advances in theranostics and oncology PET: emerging radionuclides and targets. Annals of Nuclear Medicine, 39(9), 909-921. https://doi.org/10.1007/s12149-025-02090-z

Vancouver

Watabe T, Hirata K, Iima M, Yanagawa M, Saida T, Sakata A, et al. Recent advances in theranostics and oncology PET: emerging radionuclides and targets. Annals of Nuclear Medicine. 2025;39(9):909-921. doi:10.1007/s12149-025-02090-z

BibTeX
@article{Watabe2025,
  author = {Watabe, Tadashi and Hirata, Kenji and Iima, Mami and Yanagawa, Masahiro and Saida, Tsukasa and Sakata, Akihiko and Ide, Satoru and Honda, Maya and Kurokawa, Ryo and Nishioka, Kentaro and Kawamura, Mariko and Ito, Rintaro and Takumi, Koji and Oda, Seitaro and Sugawara, Shunsuke and Sofue, Keitaro and Ueda, Daiju and Naganawa, Shinji},
  title = {Recent advances in theranostics and oncology PET: emerging radionuclides and targets},
  journal = {Annals of Nuclear Medicine},
  year = {2025},
  volume = {39},
  number = {9},
  pages = {909--921},
  doi = {10.1007/s12149-025-02090-z}
}
Kostenlos starten →